Brokerages Set Intuitive Surgical, Inc. (NASDAQ:ISRG) PT at $617.23

Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-five ratings firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, eight have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $617.2273.

Several equities analysts recently issued reports on the company. Rothschild & Co Redburn raised their price target on Intuitive Surgical from $610.00 to $615.00 and gave the stock a “buy” rating in a research report on Thursday, October 23rd. Barclays set a $712.00 price objective on Intuitive Surgical and gave the company an “overweight” rating in a research note on Monday, January 26th. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $600.00 to $654.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Truist Financial upped their price target on shares of Intuitive Surgical from $620.00 to $650.00 and gave the company a “buy” rating in a report on Thursday, December 18th. Finally, Mizuho set a $575.00 price target on shares of Intuitive Surgical in a research report on Wednesday, October 22nd.

Intuitive Surgical Stock Performance

ISRG stock opened at $478.60 on Friday. The firm has a market cap of $169.97 billion, a P/E ratio of 60.66, a P/E/G ratio of 3.84 and a beta of 1.65. The firm’s fifty day moving average is $543.41 and its 200 day moving average is $510.30. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $609.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion during the quarter, compared to the consensus estimate of $2.72 billion. During the same period in the previous year, the firm posted $2.21 earnings per share. The firm’s revenue for the quarter was up 18.8% on a year-over-year basis. As a group, analysts forecast that Intuitive Surgical will post 6.43 EPS for the current year.

Insider Activity

In other news, EVP Myriam Curet sold 421 shares of the stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total transaction of $208,378.16. Following the completion of the sale, the executive vice president directly owned 409 shares in the company, valued at approximately $202,438.64. This represents a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Fredrik Widman sold 133 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the transaction, the vice president owned 660 shares in the company, valued at approximately $326,673.60. This represents a 16.77% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 56,189 shares of company stock valued at $30,785,441. 0.70% of the stock is currently owned by insiders.

Institutional Trading of Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. SteelPeak Wealth LLC grew its position in Intuitive Surgical by 28.7% during the third quarter. SteelPeak Wealth LLC now owns 41,993 shares of the medical equipment provider’s stock valued at $18,781,000 after buying an additional 9,364 shares during the period. Amalgamated Bank boosted its stake in shares of Intuitive Surgical by 2.2% during the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock worth $44,311,000 after acquiring an additional 1,772 shares in the last quarter. Atlantic Union Bankshares Corp grew its position in shares of Intuitive Surgical by 19.3% during the 3rd quarter. Atlantic Union Bankshares Corp now owns 22,759 shares of the medical equipment provider’s stock valued at $10,179,000 after acquiring an additional 3,676 shares during the period. Sax Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 218.1% in the 2nd quarter. Sax Wealth Advisors LLC now owns 2,456 shares of the medical equipment provider’s stock valued at $1,334,000 after purchasing an additional 1,684 shares in the last quarter. Finally, Bessemer Group Inc. raised its holdings in Intuitive Surgical by 89.3% in the 2nd quarter. Bessemer Group Inc. now owns 788,328 shares of the medical equipment provider’s stock worth $428,386,000 after purchasing an additional 371,806 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Company fundamentals: Intuitive beat January quarter revenue and EPS estimates and management highlighted continued procedure growth and da Vinci 5 adoption — a reminder the growth engine remains intact. Read More.
• Positive Sentiment: Analyst support: The broker community still leans positive overall (many Buy/Overweight ratings and several price-target raises), which provides a floor if execution continues.
• Neutral Sentiment: Technicals and flow: Traders are focused on the recent pullback vs. 50‑ and 200‑day moving averages; technical positioning can amplify near‑term moves even if fundamentals are stable. Read More.
• Neutral Sentiment: Short‑interest reports in recent feeds show anomalous zero/NaN values and should be treated with caution — they don’t appear to explain today’s move.
• Negative Sentiment: Insider selling: Multiple insider sales disclosed in early February (EVP Myriam Curet and VP Fredrik Widman) are prompting short‑term negative sentiment and may be interpreted as profit‑taking. Read More. Read More.
• Negative Sentiment: Valuation and recent underperformance: Coverage questioning whether ISRG is “priced for perfection” after a pullback and a ~13% three‑month decline is keeping some investors cautious despite the beat. Read More. Read More.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.